Pharmacokinetics
-
Upload
umesh-yadav -
Category
Education
-
view
146 -
download
1
description
Transcript of Pharmacokinetics
![Page 1: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/1.jpg)
Site of ActionDosage Effects
PlasmaConcen.
Pharmacokinetics Pharmacodynamics
![Page 2: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/2.jpg)
Dose
Pla
sma
Co
nce
ntr
atio
n
0 1 2 3 4 5 6 7 8 90
2
4
6
8
10
12
TOXIC RANGE
THERAPEUTIC RANGE
SUB-THERAPEUTIC
![Page 3: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/3.jpg)
DISPOSITION OF DRUGS
The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill, 1996).
![Page 4: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/4.jpg)
Bound Free Free Bound
LOCUS OF ACTION
“RECEPTORS”TISSUE
RESERVOIRS
SYSTEMIC CIRCULATION
Free Drug
Bound Drug
ABSORPTION EXCRETION
BIOTRANSFORMATION
![Page 5: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/5.jpg)
Plasma concentration vs. time profile of a single dose of a drug ingested orally
0
2
4
6
8
10
12
14
0 5 10 15 20
TIME (hours)
Pla
sm
a C
on
cen
tra
tio
n
![Page 6: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/6.jpg)
Dose
Pla
sma
Co
nce
ntr
atio
n
0 1 2 3 4 5 6 7 8 90
2
4
6
8
10
12
TOXIC RANGE
THERAPEUTIC RANGE
SUB-THERAPEUTIC
![Page 7: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/7.jpg)
Bound Free Free Bound
LOCUS OF ACTION
“RECEPTORS”TISSUE
RESERVOIRS
SYSTEMIC CIRCULATION
Free Drug
Bound Drug
ABSORPTION EXCRETION
BIOTRANSFORMATION
![Page 8: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/8.jpg)
Bioavailability
Definition: the fraction of the administered dose reaching the systemic circulation
for i.v.: 100%for non i.v.: ranges from 0 to 100%
e.g. lidocaine bioavailability 35% due to destruction in gastric acid and liver metabolism
First Pass Effect
![Page 9: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/9.jpg)
Bioavailability
Dose
Destroyed in gut
Notabsorbed
Destroyed by gut wall
Destroyedby liver
tosystemiccirculation
![Page 10: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/10.jpg)
PRINCIPLEPRINCIPLE
For drugs taken by routes other than the i.v. route, the extent of absorption and
the bioavailability must be understood in order to determine what dose will induce the desired therapeutic effect. It will also explain why the same dose may cause a
therapeutic effect by one route but a toxic or no effect by another.
![Page 11: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/11.jpg)
Drugs appear to distribute in the body as if it were a single compartment. The magnitude of
the drug’s distribution is given by the apparent volume of distribution (Vd).
Vd = Amount of drug in body ÷ Concentration in Plasma
PRINCIPLEPRINCIPLE
(Apparent) Volume of Distribution:
Volume into which a drug appears to distribute with
a concentration equal to its plasma concentration
![Page 12: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/12.jpg)
![Page 13: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/13.jpg)
Drug L/Kg L/70 kg
Sulfisoxazole 0.16 11.2
Phenytoin 0.63 44.1
Phenobarbital 0.55 38.5
Diazepam 2.4 168
Digoxin 7 490
Examples of apparent Vd’s for some drugs
![Page 14: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/14.jpg)
K IDNEYf iltra tion
se cre tion( rea bsorp tion )
LIVERm etabo lism
se cre tion
LU NGSexha lation
O THERSm othe r's m ilk
sw ea t, sa liva e tc.
Eliminationof drugs from the body
MAJOR
MINOR
![Page 15: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/15.jpg)
Elimination by the Kidney• Excretion - major
1) glomerular filtrationglomerular structure, size constraints, protein binding
2) tubular reabsorption/secretion- acidification/alkalinization,- active transport, competitive/saturable, organic acids/bases
- protein binding
• Metabolism - minor
![Page 16: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/16.jpg)
Elimination by the Liver• Metabolism - major
1) Phase I and II reactions
2) Function: change a lipid soluble to more water soluble molecule to excrete in kidney
3) Possibility of active metabolites with same or different properties as parent molecule
• Biliary Secretion – active transport, 4 categories
![Page 17: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/17.jpg)
The enterohepatic shunt
Portal circulation
Liver
gall bladder
Gut
Bile
duct
Drug
Biotransformation;glucuronide produced
Bile formation
Hydrolysis bybeta glucuronidase
![Page 18: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/18.jpg)
Dose
Pla
sma
Co
nce
ntr
atio
n
0 1 2 3 4 5 6 7 8 90
2
4
6
8
10
12
TOXIC RANGE
THERAPEUTIC RANGE
SUB-THERAPEUTIC
![Page 19: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/19.jpg)
0
2
4
6
8
10
12
14
0 5 10 15 20
TIME (hours)
Pla
sma
con
cen
trat
ion
Influence of Variations in Relative Rates of Absorption and Elimination on Plasma
Concentration of an Orally Administered Drug
Ka/Ke=10
Ka/Ke=0.1
Ka/Ke=0.01
Ka/Ke=1
![Page 20: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/20.jpg)
Elimination
• Zero order: constant rate of elimination irrespective of plasma concentration.
• First order: rate of elimination proportional to plasma concentration. Constant Fraction of drug eliminated per unit time.
Rate of elimination ∝ AmountRate of elimination = K x Amount
![Page 21: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/21.jpg)
Zero Order Elimination Pharmacokinetics of Ethanol
• Ethanol is distributed in total body water.• Mild intoxication at 1 mg/ml in plasma.• How much should be ingested to reach it?
Answer: 42 g or 56 ml of pure ethanol (VdxC)Or 120 ml of a strong alcoholic drink like whiskey
• Ethanol has a constant elimination rate = 10 ml/h• To maintain mild intoxication, at what rate must
ethanol be taken now? at 10 ml/h of pure ethanol, or 20 ml/h of drink.
Rarely Done DRUNKENNESS
Coma Death
![Page 22: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/22.jpg)
0
2
4
6
8
10
12
14
0 5 10 15 20
TIME (hours)
Pla
sma
con
cen
trat
ion
Ct = C0 . e – Kel •t
lnCt = lnC0 – Kel • t
logCt = logC0 – Kel •t 2.3
DC/dt = – k•C
y = b – a.x
First Order EliminationdA/dt A∝ DA/dt = – k•A
![Page 23: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/23.jpg)
Time
Pla
sma
Co
nce
ntr
atio
n
0 1 2 3 4 5 61
10
100
1000
10000
First Order Elimination
logCt = logC0 - Kel . t 2.303
![Page 24: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/24.jpg)
Time
Pla
sm
a C
on
ce
ntr
ati
on
0 1 2 3 4 5 6
1
10
100
1000
10000
C0
Distribution equilibrium
Elimination only
Distribution and Elimination
Plasma Concentration Profile after a Single I.V. Injection
![Page 25: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/25.jpg)
lnCt = lnCo – Kel.t
When t = 0, C = C0, i.e., the concentration at time zero when distribution is complete and
elimination has not started yet. Use this value and the dose to calculate Vd.
Vd = Dose/C0
![Page 26: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/26.jpg)
lnCt = lnC0 – Kel.t
When Ct = ½ C0, then Kel.t = 0.693. This is the time for the plasma concentration to reach half
the original, i.e., the half-life of elimination.
t1/2 = 0.693/Kel
![Page 27: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/27.jpg)
PRINCIPLEPRINCIPLE
Elimination of drugs from the body usually follows first order
kinetics with a characteristic half-life (t1/2) and fractional rate
constant (Kel).
![Page 28: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/28.jpg)
First Order Elimination
• Clearance: volume of plasma cleared of drug per unit time.Clearance = Rate of elimination ÷ plasma conc.
• Half-life of elimination: time for plasma conc. to decrease by half.
Useful in estimating: - time to reach steady state
concentration. - time for plasma concentration to fall after dosing is stopped.
![Page 29: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/29.jpg)
IN
OUT
Blood Flow = Q
CA CV
BLOOD
BLOOD
ELIMINATED
Rate of Elimination = QCA – QCV = Q(CA-CV)
Liver Clearance = Q(CA-CV)/CA = Q x EFSIMILARLY FOR OTHER ORGANS
Renal Clearance = Ux•V/Px
Total Body Clearance = CLliver + CLkidney + CLlungs + CLx
•
![Page 30: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/30.jpg)
Rate of elimination = Kel x Amount in bodyRate of elimination = CL x Plasma Concentration
Therefore,Kel x Amount = CL x Concentration
Kel = CL/Vd
0.693/t1/2 = CL/Vd
t1/2 = 0.693 x Vd/CL
![Page 31: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/31.jpg)
PRINCIPLEPRINCIPLE
The half-life of elimination of a drug (and
its residence in the body) depends on its
clearance and its volume of distribution
t1/2 is proportional to Vd
t1/2 is inversely proportional to CL
t1/2 = 0.693 x Vd/CL
![Page 32: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/32.jpg)
Multiple dosing
• On continuous steady administration of a drug, plasma concentration will rise fast at first then more slowly and reach a plateau, where:
rate of administration = rate of elimination ie. steady state is reached.
• Therefore, at steady state:Dose (Rate of Administration) = clearance x plasma conc.
OrIf you aim at a target plasma level and you know the
clearance, you can calculate the dose required.
![Page 33: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/33.jpg)
Constant Rate of Administration (i.v.)
![Page 34: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/34.jpg)
0
1
2
3
4
5
6
7
0 5 10 15 20 25 30
Time
Pla
sma
Co
nce
ntr
atio
n
Repeated doses –Maintenance dose
Therapeutic level
Single dose – Loading dose
![Page 35: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/35.jpg)
Concentration due to a single dose
Concentration due to repeated doses
The time to reach steady state is ~4 t1/2’s
![Page 36: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/36.jpg)
Pharmacokinetic parameters
• Volume of distribution Vd = DOSE / C0
• Plasma clearance Cl = Kel .Vd
• plasma half-life t1/2 = 0.693 / Kel
• Bioavailability (AUC)x / (AUC)iv
Get equation of regression line; from it get Kel, C0 , and AUC
![Page 37: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/37.jpg)
But C x dt = small area under the curve. For total amount eliminated (which is the total given, or the
dose, if i.v.), add all the small areas = AUC. Dose = CL x AUC and Dose x F = CL x AUC
dC/dt = CL x C
dC = CL x C x dt
![Page 38: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/38.jpg)
0
10
20
30
40
50
60
70
0 2 4 6 8 10
Pla
sma
con
cen
trat
ion
Time (hours)
Bioavailability (AUC)o
(AUC)iv=
i.v. route
oral route
![Page 39: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/39.jpg)
Daily Dose (mg/kg)
Pla
sma
Dru
gC
on
cen
trat
ion
(m
g/L
)
0 5 10 150
10
20
30
40
50
60
Variability in Pharmacokinetics
![Page 40: Pharmacokinetics](https://reader035.fdocuments.in/reader035/viewer/2022070316/5560e1e2d8b42a086e8b4b41/html5/thumbnails/40.jpg)
PRINCIPLEPRINCIPLE
The absorption, distribution and elimination of a drug are qualitatively
similar in all individuals. However, for several reasons, the quantitative aspects may differ considerably. Each person must be considered individually and
doses adjusted accordingly.